|
|
Drug Discovery Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Drug Discovery Market, including, but not limited to latest business trend on : Drug Discovery; Target Quest; Target Validation; Lead Optimization; Pharmacology; ADMET; Pharmacogenomics; Metabonomics.
We offer market research, industry forecasts, and business analysis in the Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Prostate Cancer Drug Discoveries: what the future holds |
|
| Table of Contents Published: 2009/11 Published by: Espicom Business Intelligence |
| Prostate cancer (PCA) is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancer death in men. In the US, over two million men currently suffer with PCA and it is estimated that there were 192,311 new cases and ... |
| Orphan Drug Strategies |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| With the pharmaceutical industry reducing its focus on the primary care blockbuster model, Big Pharma is now looking towards the development and commercialization of more niche, high value, often biologic therapies, for the treatment of smaller patient po ... |
| Competitive Outlook on Lung Cancer Drug Development |
|
| Table of Contents Published: 2009/08 Published by: BioSeeker Group AB |
| This report includes defined and up to date development strategies for 283 lung cancer therapeutic drugs (>317 projects) within the portfolio of 167 investigators, from Ceased to Marketed. In total the report assesses three different sub-indications of lu ... |
| Competitor Analysis: Targeted Therapy of Hepatitis C |
|
| Table of Contents Published: 2009/08 Published by: La Merie |
| The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf re ... |
| Cell-Based Assays for Drug Discovery |
|
| Table of Contents Published: 2009/08 Published by: Trimark Publications |
| The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications th ... |
| U.S. Injectable Drug Pipeline |
|
| Table of Contents Published: 2009/06 Published by: Frost & Sullivan |
| This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injecta ... |
| Allergy Drug Pipeline and R&D 2009 |
|
| Table of Contents Published: 2009/06 Published by: Fuji-Keizai U.S.A., Inc. |
| This report describes current global research initiatives in the field of allergies. It focuses on the most common allergies, which affect more than 300 million persons worldwide: seasonal and perennial allergic rhinitis and food allergies. ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Merck KGaA: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Merck' s pharmaceutical operations are divided into the Merck Serono business and Consumer Health Care. For the former, research and marketing efforts are centred on two key therapeutic areas, namely Oncology and Neurology. ... |
| Epilepsy - Therapy Area Pipeline Report |
|
| Table of Contents Published: 2009/05 Published by: Life Science Analytics |
| Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overv ... |
| Approaches to Reducing Phase II Attrition |
|
| Table of Contents Published: 2009/05 Published by: Insight Pharma Reports |
| Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ... |
| The Immune/Inflammatory Pipeline: A Strategic Review |
|
| Table of Contents Published: 2009/05 Published by: Decision Resources, Inc. |
| The current immune/inflammatory pipeline is over 375 drugs strong, with approximately 250 companies involved in these agents' development. Yet, despite this robust pipeline size, Decision Resources analysts do not believe that any one agent in development ... |
| Romania Pharmaceuticals and Healthcare Report Q2 2009 |
|
| Table of Contents Published: 2009/05 Published by: Business Monitor International |
| Romania' s pharmaceutical market has experienced rapid growth over the past four years, a trend which
looks set to continue over the next five, although at a lower level. Despite the global economic downturn
having major effects on foreign exchange rate ... |
| Hungary Pharmaceuticals and Healthcare Report Q2 2009 |
|
| Table of Contents Published: 2009/05 Published by: Business Monitor International |
| Hungary' s recent history of slashing pharmaceutical prices, restricting reimbursement and squeezing
manufacturers has made the market an increasingly unattractive proposition for multinational
pharmaceutical companies. Following consistent market growt ... |
| China Pharmaceuticals and Healthcare Report Q2 2009 |
|
| Table of Contents Published: 2009/05 Published by: Business Monitor International |
| China' s pharmaceutical market is the third largest in Asia Pacific, ahead of India and behind Japan.
Combined sales of prescription products and over-the-counter (OTC) medicines reached US$36.99bn in
2008 - a 25.1% increase compared to the previous yea ... |
| European Reference Laboratories Market |
|
| Table of Contents Published: 2009/05 Published by: Frost & Sullivan |
| This short issue based research provides a top level picture of reference laboratory market in Europe with a key focus on opportunities for private laboratory service providers. ... |
| The Cardiovascular Disease Pipeline: A Strategic Review |
|
| Table of Contents Published: 2009/04 Published by: Decision Resources, Inc. |
| The robust and diverse cardiovascular disease (CVD) R&D pipeline is evidence of companies' awareness that these diseases remain leading causes of death worldwide, and that the chronic nature of many CVDs offers signifi cant commercial opportunity. ... |
| New Drug Futures |
|
| Table of Contents Published: 2009/04 Published by: Espicom Business Intelligence |
| This 450-page report evaluates, compares and contrasts the prospects for the development compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond. ... |
| Alzheimer's Disease: Markets, Pipeline and Opportunities 2009 |
|
| Table of Contents Published: 2009/04 Published by: BioPharm Reports (Technology and Markets Ltd) |
| Today' s armoury of approved drugs for the treatment of Alzheimer' s Disease (AD) largely depends on just five therapeutic agents. In 2007, three of these agents represented 88% of global sales, in a market that this report estimates exceeded $6 billion i ... |
|
| Drug Discovery Technology Alert |
|
| Issues / Year: 12 Published by: Technical Insights, Inc. |
| The Drug Discovery Technology (DDT) Alert is Technical Insights' new technology research subscription that reports and analyzes the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into ... |
|
|
|
View Cart
